Health

Hedia and Glooko Partner to Elevate Diabetes Management with Personalised Bolus Insulin Dosing

New integration delivers personalised insulin dosing advice, improving care for people with diabetes and enhancing healthcare provider insights. COPENHAGEN, Denmark and PALO ALTO, Calif., Jan. 8, 2025 /PRNewswire/ -- Glooko, Inc. and Hedia, today announced the launch of their interoperable solut...

2025-01-08 20:46 1120

Latest Updates of Viva Biotech's Portfolio Companies

HONG KONG, Jan. 8, 2025 /PRNewswire/ -- Recently, Viva Biotech's portfolio companies have new updates: TechnoDerma, VivaVision, Arthrosi, Apeiron Therapeutics and AceLink made solid progress in R&D; Full Circles published breakthrough results; Antag successfully completed financing. * TechnoDe...

2025-01-08 20:19 1892

I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member

Chairman of the Board, Wei Fu, informed the Company of his intent to purchase up to$2,000,000 of the Company's American Depository Shares (ADSs) ROCKVILLE, Md., Jan. 8, 2025 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company, focused on the development of ...

2025-01-08 20:00 895

Published in Annals of Oncology: Disitamab Vedotin Combined with PD-1 Inhibitor is a Promising Treatment for Locally Advanced or Metastatic Urothelial Carcinoma

YANTAI, China, Jan. 8, 2025 /PRNewswire/ -- On Janurary 7th, 2025, Annals of Oncology (IF: 56.7), a top oncology journal globally, published remarkable long-term follow-up results of a phase1b/2 clinical trial on Disitamab Vedotin (DV) (developed by Remegen Co., Ltd) combined with Toripalimab in ...

2025-01-08 19:08 2060

111, Inc. Announces ADS Ratio Change

SHANGHAI, Jan. 8, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream inChina, today announced that it plans to ch...

2025-01-08 18:00 1142

Alma Harmony Wins European Product Design Award in Healthcare Category

CAESAREA, Israel, Jan. 8, 2025 /PRNewswire/ -- Alma Lasers , a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, today announced that its groundbreaking multi-platform aesthetic solution, Alma Harmony, has received the prestigiou...

2025-01-08 17:00 1025

Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report

Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the twelfth annualDrugs to Watc...

2025-01-08 16:12 1364

Babies Bliss Singapore: Fertility and Maternity Wellness Services to Support Couples on Their Conception Journey

Empowering Couples to Optimize Their Health and Embrace a Holistic Path to Parenthood SINGAPORE, Jan. 8, 2025 /PRNewswire/ -- For couples facing the emotional and physical challenges of trying to conceive—whether they've experienced failed IVF cycles, multiple miscarriages, or are considering IV...

2025-01-08 15:22 1598

GenScript Biotech Becomes a PSCI Supplier Partner, Advancing a Sustainable Pharmaceutical Supply Chain

PISCATAWAY, N.J., Jan. 7, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences research and manufacturing services, has officially joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner. This milestone marks significant progress in GenScript...

2025-01-08 11:30 1047

1st Official MINISH Seminar in Tokyo. 100 Dentists Expected to Attend

SEOUL, South Korea, Jan. 8, 2025 /PRNewswire/ -- MINISH Technology Inc has announced its first clinical case seminar inJapan. The seminar will take place at the Shinagawa Season Terrace inTokyo at 1 PM on the 16th of February. The event is expected to welcome 100 dentists from acrossJapan, all re...

2025-01-08 07:10 1378

Renue by Science Launches Innovative Liposomal NAD+ Skincare Line, Renue Blue, Emphasizing Skin Wellness and Longevity

JACKSONVILLE, Fla., Jan. 8, 2025 /PRNewswire/ -- Renue by Science™, a global leader in NAD+ precursor supplements, is excited to announce the official launch of its highly anticipated skincare range, Renue Blue™. With a focus on skin longevity and holistic wellness, this revolutionary line featur...

2025-01-08 03:08 1127

MedicosBiotech Wins CES 2025 Innovation Award in Digital Health

SEOUL, South Korea, Jan. 7, 2025 /PRNewswire/ -- MedicosBiotech proudly announces its recognition at CES 2025, the world's premier technology event, as a recipient of the prestigious CES Innovation Award in the Digital Health category. This award honors excellence in innovation, technology, and d...

2025-01-08 01:00 1387

Wearable Robotics Leading Company WIRobotics to Introduce Ultra-Lightweight Walking Assistance Wearable Robot WIM to the U.S. Market

Revolutionizing Personal Mobility and Healthcare for All Ages Proven Innovation Backed by CES Awards and Success in the Korean Market YONGIN, South Korea, Jan. 7, 2025 /PRNewswire/ --  WIRobotics, a pioneering leader in wearable robotics co-led by Yeon-baek Lee and Yong-jae Kim, is set to launch...

2025-01-08 01:00 1287

Insilico Received Positive Topline Results from Two Phase 1 Trials of ISM5411, New Drug Designed Using Generative AI for the Treatment of Inflammatory Bowel Disease

* Two separate Phase I studies conducted in Australia and in China indicate that ISM5411 was generally safe and well tolerated in all dose groups, demonstrating a favorable PK profile in validating gut-restrictive properties. * Supported by Insilico's commercially-available generative AI platf...

2025-01-07 22:00 846

iWOW Unveils Age-Tech Innovations at CES 2025, Expanding Portfolio of IoT Solutions for Ageing-In-Place

SINGAPORE, Jan. 7, 2025 /PRNewswire/ -- SGX-listed iWOW Technology Limited (" iWOW" or the "Company"), a Singapore-based provider of IoT solutions, is thrilled to introduce two groundbreaking Age-Tech products at CES 2025 – theBOP Monitor and BOP Presence – which complement the existing BOP Button...

2025-01-07 21:18 5939

GORTEC Announces New Trial Success for Head and Neck Cancer Treatment

TOURS, France, Jan. 7, 2025 /PRNewswire/ -- GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab, Bristol Myers Squibb's anti-PD-1 therapy, as a post-operative treatment component for resected pa...

2025-01-07 21:00 1081

Alebund Pharmaceutical announced the 1st closing of RMB 550 million in Series C financing

SHANGHAI and YANGZHOU, China, Jan. 7, 2025 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for renal diseases and related chronic conditions, announced the closing ...

2025-01-07 21:00 1159

Verismo Therapeutics Announces Strategic Partnership with IFLI to Support SynKIR™-310 Development in Follicular Lymphoma

* Verismo will receive up to $4.05 million USD in investments from the Institute for Follicular Lymphoma Innovation (IFLI). * The partnership with IFLI will accelerate the clinical development of SynKIR™-310 in Follicular Lymphoma (FL) by leveraging IFLI's expertise and network, expanding cli...

2025-01-07 21:00 949

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

TAMPA, Fla., Jan. 7, 2025 /PRNewswire/ -- Concept Medical Inc. , a global leader in innovative drug-delivery technology, proudly reports positive outcomes from theSIRONA (Head-to-Head Comparison ofSIROlimus versus Paclitaxel Drug-Eluting BallooN Angioplasty in th...

2025-01-07 20:14 1391

Eyebright Medical Receives NMPA Class III Certificate for its Phakic Intraocular Lens

HONG KONG, Jan. 7, 2025 /PRNewswire/ -- Eyebright Medical Technology (Beijing) Co., Ltd. ("Eyebright Medical", the "Company", Stock Code: 688050.SH, together with its subsidiaries collectively known as the "Group") is proud to announce that our Phakic intraocular lens, "Loong Crystal PR", has rec...

2025-01-07 20:07 1578
1234567 ... 871